Skip to content
OpenCapital
Get started

Envoy Medical COCH Free cash flow yield

Free cash flow yield at other companies

Inspire Medical Systems logo
Inspire Medical SystemsINSP
6.5%+4.8pp

Other financials

Income statement

See full
Revenue$39.0K-15.2%
Gross profit-$274.0K-52.2%
Operating income-$6.0M-16.7%
Net income-$4.4M+12.9%
EPS (diluted)-$0.08+72.4%

Balance sheet

See full
Cash & equivalents$25.3M+376%
Total debt$919.0K-2.8%
Total equity$10.2M+142%
Total assets$29.8M+187%

Cash flow

See full
Operating cash flow-$6.1M-62.7%
CapEx$172.0K—
Free cash flow-$5.9M-28.5%

Valuation

See full
Market cap$61M+83.5%
P/S260.7×+111×

Profitability

See full
Gross margin-310.7%+31.6pp
Operating margin-9,881.2%+805pp
Net margin-9,875.6%+771pp
FCF margin-7,626.6%-652pp

Returns & leverage

See full
Return on equity328.7%—
Debt / equity0.1×—
Current ratio2.3×+1.2×

Where this comes from

Calculated from Envoy Medical’s reported figures.

free cash flow/market cap=-96.1%

Based on trailing twelve months.

The official record: Envoy Medical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Envoy Medical's free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Envoy Medical's free cash flow yield?
Envoy Medical (COCH) reported free cash flow yield of -96.1% in Q4 2025.
How has Envoy Medical's free cash flow yield changed year-over-year?
Envoy Medical's free cash flow yield decreased by 47.0% year-over-year, from -65.4% to -96.1%.
What is the long-term trend for Envoy Medical's free cash flow yield?
Over 2 years (2023 to 2025), Envoy Medical's free cash flow yield has grown at a 36.6% compound annual growth rate (CAGR), from -51.5% to -96.1%.
What does free cash flow yield mean?
Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.